National Restaurant Association Sees Continued Growth and Success by Future-proofing What Makes the Restaurant Experience Unforgettable
President & CEO Michelle Korsmo calls on restaurant operators to focus on the people, consistency and reliability that keep consumers coming to restaurants CHICAGO,... Read more.
Bonside Scorecard Launches Alongside Strategic Partnership with Kimco Realty and Nuveen Real Estate
This partnership will support the launch of Bonside’s forthcoming proprietary underwriting tool NEW YORK, May 18, 2025 /PRNewswire/ — Today, Bonside,... Read more.
Stagwell (STGW) Appoints Connie Chan as Chief Growth Officer for Asia Pacific
A catalyst for growth and innovation, Chan brings decades of cross-market expertise to power Stagwell’s next phase of growth in APAC SINGAPORE, May 18, 2025... Read more.
HKPA and Subsidiary APTEC Debut at China Print
HKPA’s 55-member delegation champions CTV Program to boost print productivity HONG KONG, May 18, 2025 /PRNewswire/ — In a landmark move for the printing... Read more.
Club Offers Released on May 18, 2025
LONDON, May 17, 2025 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces the release of Club Offers for Club Members. Rigorously... Read more.
CHAI, the Social AI Platform, on Track to Hit $1.4B Valuation in 2026
CHAI, a fast-rising AI startup in Palo Alto, is rapidly emerging as the next unicorn with explosive revenue growth of 250%, surpassing industry leaders like Databricks... Read more.
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
World Hypertension Day’s focus on High Blood Pressure Awareness, Management and Control highlights Importance of New Therapies, like Ultrasound Renal Denervation... Read more.
GMI Cloud Scales Up With New HQ in Mountain View, CA
GMI Cloud deepens existing Silicon Valley roots, prioritizing collaboration with leading AI innovators MOUNTAIN VIEW, Calif., May 16, 2025 /PRNewswire/ — GMI... Read more.
WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA
Enabled by WuXi Biologics’ industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to commercialization.... Read more.
2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH
——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 16,... Read more.